Another big firm blog today, this one from Foley & Lardner. PharmaPatents aims to serve as an online resource for up-to-date information to help companies make the most of their patent budgets and meet the challenges of maximizing the value of intellectual property in the chemical, biotech, and pharmaceutical fields. Of late, Editor Courtenay Brinckerhoff has been discussing patent reform, human antibody claims, license agreements, and “definiteness.”